Comparable stake leader
Francois Lebel
SEC ownership of SPECTRUM PHARMACEUTICALS INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000831547.
Disclosed value leader
Francois Lebel
Comparable rows
0/4
Latest evidence
21 Jun 2022
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Francois Lebel
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
21 Jun 2022
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000831547
- Issuer location
- Henderson, NV
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of SPECTRUM PHARMACEUTICALS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Francois Lebel
Disclosed value leader
Francois Lebel
Comparable rows
0/4
Latest evidence
21 Jun 2022
3/4/5
Highest disclosed value: $714,610
4 rows are not safely comparable across share classes.
Quick read
Francois Lebel has the largest disclosed position value at $714.6K.
0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Francois Lebel's linked filing trail.
Disclosed position value
Top 4
Francois Lebel
$714.6K
Kurt A. Gustafson
$360.7K
Dolatrai Vyas
$89.9K
Bernice R. Welles
$70.4K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-4 of 4 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Francois Lebel |
3/4/5
Chief Medical Officer
|
—
mixed-class rows
|
$714,610
2,140,956 shares
mixed-class rows
|
— | 21 Jun 2022 |
| Kurt A. Gustafson |
3/4/5
EVP & Chief Financial Officer
|
—
class O/S missing
|
$360,693
329,099 shares
|
— | 15 Mar 2022 |
| Dolatrai Vyas |
3/4/5
Former Director
|
—
class O/S missing
|
$89,941
82,063 shares
|
— | 21 Jun 2022 |
| Bernice R. Welles |
3/4/5
Director
|
—
mixed-class rows
|
$70,448
132,081 shares
mixed-class rows
|
— | 17 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to SPECTRUM PHARMACEUTICALS INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Francois Lebel
Net 12M change
$0
Latest report
31 Jul 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Francois Lebel | Chief Medical Officer | $714,610 | Mixed | 21 Jun 2022 | ||
| Kurt A. Gustafson | EVP & Chief Financial Officer | $360,693 | Mixed | 15 Mar 2022 | ||
| Dolatrai Vyas | Former Director | $89,941 | Mixed | 21 Jun 2022 | ||
| Bernice R. Welles | Director | $70,448 | Mixed | 17 Jun 2021 | ||
| Thomas J. Riga | President and Chief Executive Officer, Director | Mixed | 31 Jul 2023 | |||
| Keith M. McGahan | Executive Vice President, Chief Legal Officer and Corporate Secretary | Mixed | 31 Jul 2023 | |||
| Jeff L. Vacirca | Director | Mixed | 31 Jul 2023 | |||
| Brittany Bradrick | Director | Mixed | 31 Jul 2023 | |||
| Juhyun Lim | Director | Mixed | 31 Jul 2023 | |||
| Seth H. Z. Fischer | Director | Mixed | 31 Jul 2023 | |||
| William L. Ashton | Director | Mixed | 31 Jul 2023 | |||
| Nora Brennan | Executive Vice President and Chief Financial Officer | Mixed | 31 Jul 2023 |
Recent insider transactions for SPECTRUM PHARMACEUTICALS INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.